Merck discontinues some cancer drug development with China's Sichuan Kelun
By Andrew Silver SHANGHAI, Oct 23 (Reuters) - Chinese drugmaker Sichuan Kelun Pharmaceutical Co said on Monday that Merck & Co Inc was abandoning the joint development of two candidate cancer drugs w...